[{"Assets_0_FY_USD":1562700000.0,"CommonStockSharesOutstanding_0_FY_shares":73500000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":83700000.0,"NetIncomeLoss_1_FY_USD":-4200000.0,"NetIncomeLoss_4_FY_USD":4600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":73500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":73400000.0,"StockholdersEquity_0_FY_USD":1088900000.0,"EarningsPerShareBasic_4_FY_USD":0.06,"EarningsPerShareBasic_1_FY_USD":-0.06,"Ticker":"MYGN","CIK":"899923","name":"MYRIAD GENETICS INC","OfficialName":"Myriad Genetics Inc. Common Stock","form":"10-K","period":"20190630","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1850258412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20190813"}]